1. Home
  2. POWL vs IBRX Comparison

POWL vs IBRX Comparison

Compare POWL & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Powell Industries Inc.

POWL

Powell Industries Inc.

N/A

Current Price

$208.74

Market Cap

8.5B

Sector

Energy

ML Signal

N/A

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

N/A

Current Price

$7.59

Market Cap

7.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
POWL
IBRX
Founded
1947
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
7.5B
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
POWL
IBRX
Price
$208.74
$7.59
Analyst Decision
Buy
Strong Buy
Analyst Count
4
7
Target Price
$184.25
$12.57
AVG Volume (30 Days)
819.2K
9.0M
Earning Date
05-04-2026
05-08-2026
Dividend Yield
0.14%
N/A
EPS Growth
N/A
38.71
EPS
3.81
N/A
Revenue
$448,716,000.00
$113,288,000.00
Revenue This Year
$11.20
$88.59
Revenue Next Year
$9.12
$131.15
P/E Ratio
$54.48
N/A
Revenue Growth
13.34
668.31
52 Week Low
$178.05
$1.95
52 Week High
$612.50
$12.43

Technical Indicators

Market Signals
Indicator
POWL
IBRX
Relative Strength Index (RSI) 41.21 51.28
Support Level $181.33 $6.68
Resistance Level $248.33 $8.46
Average True Range (ATR) 14.39 0.38
MACD 1.39 0.05
Stochastic Oscillator 38.17 89.05

Price Performance

Historical Comparison
POWL
IBRX

About POWL Powell Industries Inc.

Powell Industries Inc is a United States-based company that develops, designs, manufactures, and services custom-engineered equipment and systems for electrical energy distribution, control, and monitoring. The company's principal products comprise integrated power control room substations, custom-engineered modules, electrical houses, traditional and arc-resistant distribution switchgear and control gear, and so on. These products are applied in oil and gas refining, offshore oil and gas production, petrochemical, pipeline, terminal, mining and metals, light-rail traction power, electric utility, pulp and paper, and other heavy industrial markets. The company generates the majority of its sales from the United States, and the rest from Canada, Europe, Asia Pacific, and other regions.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

Share on Social Networks: